MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
    • CCSVI
    • Epstein Barr Virus
    • Neuroimaging
    • Ocular Motor
    • Stem Cells
    • Type 1 Diabetes
    • Vitamin D
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Employment & MS
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • Kriesel Lab
    • Jelinek Group
    • MitoQ
    • Support MS Research
  • Connect
    • Live Research Q&A
    • eBooks
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Mesenchymal Stem Cell Trial for Multiple Sclerosis
  • BEAT-MS Trial to Compare AHSCT to MS Treatments
  • Facebook Live: Research Update - December 2019
  • Research Reflections: Siponimod Trial Results
  • Emerging Themes in Multiple Sclerosis Research
  • Employment & Multiple Sclerosis: Feature Week
  • HOME
  • Research
    • Basic Sciences
    • CCSVI
    • Epstein Barr Virus
    • Neuroimaging
    • Ocular Motor
    • Stem Cells
    • Type 1 Diabetes
    • Vitamin D
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Employment & MS
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • Kriesel Lab
    • Jelinek Group
    • MitoQ
    • Support MS Research
  • Connect
    • Live Research Q&A
    • eBooks
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
body mass index

Body Mass Index (BMI) Linked to Brain Volume Loss

MStranslate
June 18, 2019
Lifestyle, Research
There is an increasing focus on the role that lifestyle changes may play in helping to manage multiple sclerosis. Factors such as diet, exercise, mindfulness, vitamin D levels and smoking habits are all...
World MS Day

Facebook Live: World MS Day Research Update

MStranslate
June 11, 2019
Research, Videos
On World MS Day 2019 (May 29), MStranslate co-founder and chief science communicator, Brett Drummond, took to Facebook Live to provide a comprehensive update on the latest developments in multiple sclerosis...
gut bacteria

Treatment With Gut Bacteria Shows Benefits In New Study

MStranslate
May 2, 2019
Research, Treatments
Research Summary: Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis Many people living with multiple sclerosis say they have experienced...
stem cells

Stem Cells in Hair Follicles Show Myelin Repair Potential

MStranslate
April 30, 2019
Remyelination, Research, Stem Cells
Research Summary: CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties Myelin repair or remyelination is considered by many, including an overwhelming majority of our...
exercise training

Exercise Barriers in Multiple Sclerosis: Falling

MStranslate
April 4, 2019
Exercise, Lifestyle, Movement Disorders, Rehabilitation, Research
It won’t come as a surprise to many that research has shown regular exercise can be especially important for people living with multiple sclerosis. In particular it has been shown to lead to improvements in...
Mavenclad

FDA Approves Second Drug For Active SPMS

MStranslate
April 1, 2019
Research, Treatments
Late last week, it was announced that Mavenclad (cladribine) received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS). Importantly, this also includes people living...
employment

Research Into Employment Issues for PwMS

MStranslate
March 28, 2019
Lifestyle, Research
The following article was commissioned by MS Limited and has previously been published in their eNewsletter, Intouch.  We are revisiting this topic following the large response to our Facebook poll last...
siponimod

New Treatment Approved for Active SPMS

MStranslate
March 27, 2019
Research, Treatments
1 Comment
It was announced earlier today that Mayzent (siponimod) has received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS).  Importantly, this also includes people living...
relationships

Relationships and Multiple Sclerosis

MStranslate
March 20, 2019
Lifestyle, Research
The following article was commissioned by MS Limited and has previously been published in their eNewsletter, Intouch.     As most of us have probably found out at some point in our...
Cocoa

Does a Cocoa a Day Keep MS Fatigue Away?

MStranslate
March 19, 2019
Fatigue, Research, Treatments
Research Summary: A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis Fatigue is one of the most...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • Mesenchymal Stem Cell Trial for Multiple Sclerosis
  • BEAT-MS Trial to Compare AHSCT to MS Treatments
  • Facebook Live: Research Update – December 2019
  • Research Reflections: Siponimod Trial Results
  • Emerging Themes in Multiple Sclerosis Research

Recent Comments

  • BEAT-MS Trial to Compare AHSCT to Other MS Treatments on Research Reflections: Siponimod Trial Results
  • BEAT-MS Trial to Compare AHSCT to Other MS Treatments on HSCT Trial Shows Positive Results for RRMS
  • laurie marney on Fasting & Metformin Improve Myelin Repair
  • Cathy D'Alterio on Fasting & Metformin Improve Myelin Repair
  • ECTRIMS 2019: Final Thoughts From Stockholm - MStranslate on Improving Quality of Life in Multiple Sclerosis

Calendar

February 2020
M T W T F S S
« Jan    
 12
3456789
10111213141516
17181920212223
242526272829  

Archives

  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • March 2013
  • February 2013
  • December 2012
  • October 2012

Categories

  • Alemtuzumab
  • B Cells
  • Basic Sciences
  • Behind the Scenes
  • Biotin
  • CCSVI
  • Clinical Trials
  • Cognition
  • Collaboration
  • Community
  • Conferences
  • Daclizumab
  • Diet
  • Dimethyl fumarate
  • ECTRIMS
  • Epstein-Barr Virus
  • Events
  • Exercise
  • Fatigue
  • Feedback
  • Fingolimod
  • Genetics
  • Google Hangouts
  • Hormones
  • Infection
  • Interferon-beta
  • Laquinimod
  • Lifestyle
  • Medicinal Cannabis
  • Mental Health
  • MIS416
  • Movement Disorders
  • MS: Many Stories
  • MStranslate
  • Natalizumab
  • Neuroimaging
  • Ocrelizumab
  • Ocular Motor
  • Opinion
  • Presentations
  • Progressive MS
  • Q&A
  • Quality of Life
  • Recruitment
  • Rehabilitation
  • Remyelination
  • Research
  • Rituximab
  • Social Media
  • Stem Cells
  • Symposium
  • Treatments
  • Type 1 Diabetes
  • Uncategorized
  • Understanding Science
  • Videos
  • Vitamin D

Posts

  • Mesenchymal Stem Cell Trial for Multiple Sclerosis
  • BEAT-MS Trial to Compare AHSCT to MS Treatments
  • Facebook Live: Research Update – December 2019
  • Research Reflections: Siponimod Trial Results
  • Emerging Themes in Multiple Sclerosis Research

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us